| Literature DB >> 30954463 |
Xiang-Tao Huang1, Xi Li1, Ming-Ling Xie1, Zhen Huang1, Yong-Xiu Huang1, Gui-Xian Wu1, Zhi-Rong Peng1, Yan-Ni Sun1, Qian-Liang Ming2, Yan-Xia Liu2, Jie-Ping Chen3, Shuang-Nian Xu4.
Abstract
Resveratrol, found in variety of plants, is a natural stilbene structure polyphenol. It has various pharmacological effects, such as antioxidation, anti-aging, anti-inflammation, anti-cancer, antiobesity, anti-diabetes, cardioprotection, neuroprotection. Recently, anti-leukemia activities of resveratrol has been studied extensively via its effects on a variety of biological processes involving cell proliferation, apoptosis, autophagy. Current treatments of leukemia mainly rely on intensive chemotherapy or hematopoietic stem cell transplantation, however, these treatments are still with poor survival and high treatment-related mortality. Therefore, it is extremely needed to find relatively non-toxic medicines with minimal side effects but sufficient therapeutic efficacy. Resveratrol is one such potential candidate owing to its reported anti-leukemia effect. In this review, we summarized resveratrol's discovery, sources and isolation methods, administration methods, effects in different types of leukemia, pharmacokinetics and toxicities, aiming to exploit resveratrol as a potential drug candidate for anti-leukemia.Entities:
Keywords: Anti-Leukemia; Drug candidate; Resveratrol
Mesh:
Substances:
Year: 2019 PMID: 30954463 DOI: 10.1016/j.cbi.2019.04.001
Source DB: PubMed Journal: Chem Biol Interact ISSN: 0009-2797 Impact factor: 5.192